Dr. Shmulik Hess
Dr. Shmulik Hess
Founder & Executive Board Member
Dr. Shmulik Hess is the CEO Enlivex Therapeutics. Dr. Hess received his PhD in Pharmaceutical Science from the Hebrew University, Israel and was a research fellow atHarvard-MIT Health Sciences and Technology (HST) Dr. Hess has gained numerous patents and publications in peer reviewed scientific journals. Prior to joining Enlivex Dr. Hess served as the CEO of Valin Technologies since inception overseeing the execution of the company activities and its achievements including the development and technology transfer of several biosimilars and the in-licensing and acquisition of three early stage innovative projects and the further drug development process. Prior to joining Valin Technologies Dr. Hess was founder and CEO of ActivePx, a biotech company engaged in the development of oral available peptides for the treatment of pain. Following which he served as associate global operations at Scigen LTD (NASDAQ: VBIV), where he supported the establishment of a state of the art vaccine manufacturing facility for SciBvac® as well as a biologic manufacturing facility in India. Dr. Hess is co-founder and chairman of ScienceAbroad an NGO dedicated to encouraging and support the return Israeli scientist from abroad. Dr. Hess has experience with drug development, process development and scale-up of biologics and GMP manufacturing.